Log In
Print
BCIQ
Print
Print this Print this
 

Firazyr, icatibant

Also known as: JE049

  Manage Alerts
Collapse Summary General Information
Company Sanofi
DescriptionSelective peptidomimetic bradykinin B2 receptor antagonist
Molecular Target Bradykinin B2 receptor (BDKRB2) (B2R)
Mechanism of ActionBradykinin receptor antagonist
Latest Stage of DevelopmentMarketed
IndicationAngioedema
Partner

Shire plc
 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today